90.1.6.11.2 Specimen Collection: Clinical Laboratories, Blood Collection, Tube Requirements and Normal Intervals
100 East 77th Street
New York, N.Y. 10075
Specimen Collection: Clinical Laboratories, Blood Collection, Tube
Requirements and Normal Intervals
Name, Position
Author/Approvin
g Authority:
Oana Vele, MD
Director of Clinical Pathology
Date Issued:
6/7/2010
Annual Review/ Revisions
Date
Signature
Signature on file
2/05, 5/09,
5/10, 2/11,
9/12, 3/02
06/2014;
01/2015;
02/16/15;
10/2015
Oana Vele, MD - signature on file
Signature
Date
6/7/2010
Date
Signature
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
OVERVIEW:
CHEMISTRY
FLUIDS CHEMISTRY
URINE CHEMISTRY
HEMATOLOGY
COAGULATION
SEROLOGY
MISCELLANEOUS
APPENDIX
2-8
8-10
10-13
13-14
14-16
16-18
19
20-23
METHOD KEY:
C
CER
CIA
CMIA
D
DSI
EIA
IR
LOCI
LA
N
PA
PETINIA
R
RICA
Colorimetric
Coupled enzyme reaction
Chemiluminescent Immunometric Assay
Chemiluminescent Microparticle Immunoassay
Dipstick
Direct Solid-phase Immunoassay
Enzyme Immunoassay
Immuno Rate
Luminescent Oxygen Channeling Assay
Latex agglutination
Nephelometric
Particle agglutination
Particle Enhanced Turbidimetric Inhibition Immunoassay
Rate bichromatic
Rapid Immunochromatographic Assay
Page 1 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
COLLECTION TUBE REQUIREMENTS AND NORMAL INTERVALS
CHEMISTRY
METHOD
SEE
INDIVIDUAL
TEST
SEE
INDIVIDUAL
TEST
PANEL/TEST
NAME
BASIC METABOLIC
PANEL
COMPREHENSIVE
METABOLIC PANEL
TEST(S)
SODIUM, POTASSIUM,
CHLORIDE, CARBON DIOXIDE,
CALCULATED ANION GAP
GLUCOSE, BUN, CREATININE,
CALCULATED EGFR,
CALCIUM
SODIUM, POTASSIUM
CHLORIDE, CARBON
DIOXIDE, CALCULATED ANION
GAP, GLUCOSE, BUN
CREATININE, CALCULATED
EGFR, CALCIUM
TOTAL PROTEIN, ALBUMIN
TOTAL BILIRUBIN, ALKALINE
TUBE
NORMAL INTERVAL
MINT TOP
SEE INDIVIDUAL TEST
ANION GAP: 9-16 MMOL/L
MINT TOP
SEE INDIVIDUAL TEST
PHOSPHATASE
ALT/SGPT, AST/SGOT
SEE
INDIVIDUAL
TEST
CARDIAC PANEL
CREATINE KINASE, MMB
FRACTION, TROPONIN I
MINT TOP
SEE INDIVIDUAL TEST
TOTAL CK WITH MMB
CREATINE KINASE, MASS OF
MB ISOENZYME (MMB)
FRACTION
CALCULATED MMB/CK %
WHEN MMB >=5 NG/ML
MINT TOP
MMB 0.5-3.6 NG/ML
MMB/CK % =<4%
ELECTROLYTE
PANEL
SODIUM, POTASSIUM,
CHLORIDE, CARBON DIOXIDE
MINT TOP
SEE INDIVIDUAL TEST
HEPATIC FUNCTION
PANEL
TOTAL PROTEIN, ALBUMIN
TOTAL BILIRUBIN, DIRECT
BILIRUBIN, CALCULATED
INDIRECT BILIRUBIN,
ALKALINE
PHOSPHATASE
ALT/SGPT, AST/SGOT
MINT TOP
SEE INDIVIDUAL TEST
R AND
LOCI
SEE
INDIVIDUAL
TEST
SEE
INDIVIDUAL
TEST
Page 2 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
SEE
INDIVIDUAL
TEST
MINT TOP
SEE INDIVIDUAL TEST
FOR LDL-C
<100 MG/DL OPTIMAL
100-129 MG/DL LOW RISK
130-159 MG/DL BORDERLINE
HIGH
160-189 MG/DL HIGH
190 MG/DL OR > VERY HIGH
GOLD TOP
SEE INDIVIDUAL TEST
TRANSFERRIN SATURATION
20-38 % FEMALES
26-39 % MALES
LIPID PANEL
CHOLESTEROL
HDL-C, LDL-C (CALCULATED
VALUE), TRIGLYCERIDES
SEE
INDIVIDUAL
TEST
IRON PANEL
IRON
TIBC
TRANSFERRIN SATURATION
(CALCULATED)
FERRITIN
C
ACETAMINOPHEN
ACETAMINOPHEN
GOLD TOP
THERAPEUTIC INTERVAL:
10.0-30.0 MCG/ML
C
ALBUMIN
ALBUMIN
MINT TOP
3.4-5.0 GM/DL
R
ALCOHOL
ALCOHOL
GOLD TOP
< 3 MG/DL
R
ALKALINE
PHOSPHATASE
ALKALINE PHOSPHATASE
MINT TOP
0 days 40-350 U/L
10 years 40-280 U/L
15 years 40-150 U/L
20 years 45-117 U/L
MINT TOP
12-42 U/L
10-32 MCMOL/L
R
ALT/SGPT
SERUM ALANINE
AMINOTRANSFERASE
GLUTAMIC PYRUVATE
TRANSAMINASE
R
AMMONIA
AMMONIA
MINT TOP
ON ICE
R
AMYLASE
AMYLASE
MINT TOP
R
AST/SGOT
C
BETA HYDROXY
BUTYRATE
ASPARATE
AMINOTRANSFERASE
GLUTAMATE OXALACETATE
TRANSAMINASE
BETA
HYDROXYBUTYRATE, SERUM
MINT TOP
25-115 U/L
15-37 U/L
0.0 - 0.4 MMOL/L
GOLD TOP
Page 3 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
LOCI
C
C
CALCULA
TED
BETA HUMAN
CHORIONIC
GONADOTROPIN
QUANTITATIVE
DIRECT BILIRUBIN
TOTAL BILIRUBIN
BOTH DIRECT AND
TOTAL BILIRUBIN
ARE TESTED
NON-PREGNANT FEMALES,
AGES 18-62: 1-3 MIU/ML
BHCG, QUANTITATIVE
DIRECT (CONJUGATED)
BILIRUBIN
MINT TOP
MINT TOP
MALES, AGES 19-67:
=< 1 MIU/ML
0-0.2 MG/DL
MINT TOP
0 days 2.0-6.0 MG/DL
1 day 6.0-10.0 MG/DL
3 days 4.0-8.0 MG/DL
6 days 0.2-1.2 MG/DL
29 days 0.2-1.2 MG/DL
18 y.o. 0.2-1.0 MG/DL
INDIRECT BILIRUBIN
MINT TOP
0 days 2.0-5.8 MG/DL
1 day 6.0-9.8 MG/DL
3 days 4.0-7.8 MG/DL
6 days 0.2-1.2 MG/DL
29 days 0.2-1.0 MG/DL
TOTAL BILIRUBIN
R
BLOOD UREA
NITROGEN
BLOOD UREA NITROGEN
MINT TOP
7-23 MG/DL
C
CALCIUM
CALCIUM
MINT TOP
8.5-10.5 MG/DL
N
CARBAMAZEPINE
CARBAMAZEPINE
MINT TOP
THERAPEUTIC INTERVAL:
4.0-12.0 MCG/ML
C
CARBON DIOXIDE
P
CHLORIDE
C
CMIA
CMIA
CHOLESTEROL
CARBON DIOXIDE, TOTAL
CHLORIDE
MINT TOP
ADULTS: 22-31 MMOL/L
NEONATES: 13-22 MMOL/L
MINT TOP
96-108 MMOL/L
MINT TOP
< 200 MG/DL DESIRABLE
200-239 MG/DL BORDERLINE
HIGH
>239 MG/DL HIGH
CHOLESTEROL
CORTISOL
A.M.
A.M. CORTISOL LEVEL
8-10 A.M.
GOLD TOP
3.9- 37.5 MCG/DL
CORTISOL
P.M.
P.M. CORTISOL LEVEL
4-6 P.M.
GOLD TOP
2.3-13.8 MCG/DL
Page 4 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
N
C-REACTIVE
PROTEIN
R
CREATINE KINASE
CE
CREATININE
CKD-EPI
EQUATION
CALCULATED WHEN
CREATININE IS
TESTED on
PATIENTS >18 Y.O.
R
LOCI
LOCI
DIGOXIN
FERRITIN
FREE
TRIIODOTHYRONINE
C-REACTIVE PROTEIN
CREATINE KINASE
MINT TOP
< 0.30 MG/DL
MINT TOP
FEMALE: 26-192 U/L
MALE: 39-308 U/L
MINT TOP
0 days 0.20-0.70 MG/DL
10 years 0.50-1.30 MG/DL
MINT TOP
>=60 ML/MIN
MINT TOP
THERAPEUTIC INTERVAL:
0.8-2.0 NG/ML
GOLD TOP
FEMALE:8-252 NG/ML
MALE: 26-388 NG/ML
CREATININE, IDMS
ESTIMATED GLOMERULAR
FILTRATION RATE
DIGOXIN
FERRITIN
FREE TRIIODOTHYRONINE
MINT TOP
1.71-3.71 PG/ML
MINT TOP
0.70-1.48 NG/DL
LOCI
FREE THYROXINE
FREE THYROXINE
R
GAMMA GLUTAMYL
TRANSFERASE
GAMMA GLUTAMYL
TRANSFERASE (GGT)
N
GENTAMICIN
TROUGH
GENTAMICIN
TROUGH
GOLD TOP
THERAPEUTIC INTERVAL:
0-2.0 MCG/ML
N
GENTAMICIN
PEAK
GENTAMICIN
PEAK
GOLD TOP
THERAPEUTIC INTERVAL:
4.0-8.0 MCG/ML
N
GENTAMICIN
RANDOM
GENTAMICIN
RANDOM
C
GLUCOSE, NON
FASTING, PART OF
BMP AND CMP
GLUCOSE
MINT TOP
C
GLUCOSE, FASTING
GLUCOSE
GRAY TOP
MINT TOP
GOLD TOP
FEMALE: 5-55 U/L
MALE: 15-85 U/L
NO REFERENCE RANGE
70-99 MG/DL
70-99 MG/DL
Page 5 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
GRAY TOP
C
GLUCOSE, RANDOM
GLUCOSE
C
GLUCOSE
CHALLENGE TEST,
GESTATIONAL
SCREEN (50 G
GLUCOSE LOAD)
GLUCOSE
C
C
C
ORAL GLUCOSE
TOLERANCE TEST
2 HRS (75 G
GLUCOSE LOAD)
ORAL GLUCOSE
TOLERANCE TEST
3 HRS (100 G
GLUCOSE LOAD)
GLUCOSE, 2 HRS
POST GLUCOLA
(75 G GLUCOSE
LOAD)
GRAY TOP
GRAY TOP
GLUCOSE
GRAY TOP
<140 MG/DL
GRAY TOP
<140 MG/DL
N
HAPTOGLOBIN
HAPTOGLOBIN
PETINIA
HEMOGLOBIN A1C
PERCENTAGE OF GLYCATED
HEMOGLOBIN
C
HDL-C
HDL-C
CMIA
INTRAOPERATIVE
PARATHORMONE
LACTOSE
TOLERANCE TEST
(LACTOSE DOSE:
50 G)
SEE REPORT
GLUCOSE
GLUCOSE
C
SEE REPORT
GRAY TOP
GLUCOSE, 2 HRS,
POSTPRANDIAL
LACTIC ACID
<140 MG/DL
GLUCOSE
C
C
70-139 MG/DL
MINT TOP
LAVENDER
TOP
MINT TOP
31-207 MG/DL
4.8-5.6%
<40 LOW (FLAGGED)
>=60 HIGH
INTRAOPERATIVE
PARATHORMONE
LAVENDER
TOP
8.5-72.5 PG/ML
LACTIC ACID, WHOLE BLOOD
DARK
GREEN
TOP ON ICE
0.5-2.0 MMOL/L
GLUCOSE
GRAY TOP
SEE REPORT
Page 6 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
R
R
LACTATE DEHYDROGENASE
LIPASE
LACTATE DEHYDROGENASE
MINT TOP
FEMALE: 84-246 U/L
MALE: 87-241 U/L
LIPASE
MINT TOP
73-393 U/L
GOLD TOP
THERAPEUTIC INTERVAL:
0.6-1.2 MMOL/L
MINT TOP
1.6-2.4 MG/DL
MINT TOP
FEMALE: 13-71 NG/ML
MALE: 16-116 NG/ML
C
LITHIUM
LITHIUM
C
MAGNESIUM
MAGNESIUM
LOCI
MYOGLOBIN
MYOGLOBIN
LOCI
NT-PRO BNP
NT-PRO BNP
MINT TOP
<300 PG/ML
FP
OSMOLALITY,
SERUM
OSMOLALITY
GOLD TOP
280-301 MOSM/KG
PETINIA
PHENOBARBITAL
PHENOBARBITAL
GOLD TOP
THERAPEUTIC INTERVAL:
15-40 MCG/ML
C
P
PHOSPHORUS
POTASSIUM,
PLASMA
N
PREALBUMIN
CMIA
PROSTATE SPECIFIC
ANTIGEN
PETINIA
PHENYTOIN
(DILANTIN)
C
SALICYLATE
MINT TOP
0-6 weeks: 4.2 - 9.0 MG/DL
6 weeks-18 months: 3.8 - 6.7
MG/DL
18 months-3 yrs = 2.9 - 5.9
MG/DL
3-15 yrs = 3.6 - 5.6 MG/DL
>15yrs = 2.5 - 4.5 MG/DL
MINT TOP
3.5-5.1 MMOL/L
PHOSPHORUS
POTASSIUM
PREALBUMIN
PROSTATE SPECIFIC
ANTIGEN
MINT TOP
GOLD TOP
0.0-4.0 NG/ML
GOLD TOP
THERAPEUTIC INTERVAL
10-20 MCG/ML
GOLD TOP
THERAPEUTIC INTERVAL:
2.8-20.0 MG/DL
PHENYTOIN (DILANTIN)
SALICYLATE
20-40 MG/DL
Page 7 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
P
C
SODIUM
TOTAL PROTEIN
SODIUM
TOTAL PROTEIN
MINT TOP
MINT TOP
135-145 MMOL/L
6.4- 8.2 G/DL
3.17-11.72 MCG/DL
IR
THYROXINE
THYROXINE
PETINIA
THEOPHYLLINE
THEOPHYLLINE
N
TRANSFERRIN
TRANSFERRIN
C
TRIGLYCERIDES
TRIGLYCERIDES
MINT TOP
<150 MG/DL
LOCI
TROPONIN I
TROPONIN I
MINT TOP
0.015- 0.045 NG/ML
THYROID
STIMULATING
HORMONE
THYROID
STIMULATING HORMONE
(TSH)
MINT TOP
LOCI
C
URIC ACID
URIC ACID
PETINIA
VALPROIC ACID
PETINIA
VANCOMYCIN
TROUGH
PETINIA
VANCOMYCIN
RANDOM
VALPROIC ACID
MINT TOP
GOLD TOP
MINT TOP
THERAPEUTIC INTERVAL:
10-20 MCG/ML
200-360 MG/DL
0.35-4.94 MCIU/ML
MINT TOP
FEMALE: 2.6-6.0 MG/DL
MALE: 3.5-7.2 MG/DL
GOLD TOP
50-100 MCG/ML
VANCOMYCIN TROUGH
MINT TOP
10-20 MCG/ML
VANCOMYCIN RANDOM
MINT TOP
NO REFERENCE RANGE
Page 8 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
FLUIDS CHEMISTRY
METHOD
PANEL/TEST
NAME
SAME AS
FOR
PLASMA
BASIC
METABOLIC
PANEL
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
COMPREHENSIVE
METABOLIC PANEL
TEST(S)
SODIUM, POTASSIUM,
CHLORIDE, CARBON
DIOXIDE, GLUCOSE,
BUN, CREATININE
CALCIUM
SODIUM,POTASSIUM
CHLORIDE, CARBON
DIOXIDE , GLUCOSE,
BUN, CREATININE ,
CALCIUM
TOTAL PROTEIN ,
ALBUMIN
TOTAL BILIRUBIN ,
ALKALINE
PHOSPHATASE
ALT/SGPT, AST/SGOT
CONTAINER
NORMAL
INTERVAL
STERILE
CONTAINER
NO REFERENCE
RANGE
STERILE
CONTAINER
NO REFERENCE
RANGE
ALBUMIN, FLUID
ALBUMIN
STERILE
CONTAINER
NO REFERENCE
RANGE
AMYLASE, FLUID
AMYLASE
STERILE
CONTAINER
NO REFERENCE
RANGE
BILIRUBIN, FLUID
BILIRUBIN
STERILE
CONTAINER
NO REFERENCE
RANGE
CALCIUM, FLUID
CALCIUM
STERILE
CONTAINER
NO REFERENCE
RANGE
CHOLESTEROL,
FLUID
CHOLESTEROL
STERILE
CONTAINER
CREATININE,
FLUID
CREATININE
STERILE
CONTAINER
GLUCOSE, FLUID
GLUCOSE
STERILE
CONTAINER
NO REFERENCE
RANGE
NO REFERENCE
RANGE
NO REFERENCE
RANGE
Page 9 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
C
LACTATE
DEHYDROGENASEF
LUID
LACTATE
DEHYDROGENASE
STERILE
CONTAINER
NO REFERENCE
RANGE
LIPASE, FLUID
LIPASE
STERILE
CONTAINER
NO REFERENCE
RANGE
POTASSIUM,
FLUID
POTASSIUM
STERILE
CONTAINER
NO REFERENCE
RANGE
SODIUM, FLUID
SODIUM
STERILE
CONTAINER
NO REFERENCE
RANGE
STERILE
CONTAINER
NO REFERENCE
RANGE
STERILE
CONTAINER
NO REFERENCE
RANGE
STERILE
CONTAINER
12-60 MG/DL
TOTAL PROTEIN,
FLUID
TOTAL PROTEIN
TRIGLYCERIDES,
FLUID
TRIGLYCERIDES
CEREBROSPINAL
FLUID
PROTEIN
C
CEREBROSPINAL
FLUID
GLUCOSE
C
SIP
GLUCOSE
CEREBROSPINAL
FLUID
CHEMISTRY
GLUCOSE
PROTEIN
FETAL
FIBRONECTIN
FETAL
FIBRONECTIN,
VAGINAL FLUID
STERILE
CONTAINER
STERILE
CONTAINER
STERILE
CONTAINER
40-70 MG/DL
40-70 MG/DL
12-60 MG/DL
NEGATIVE
Page 10 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
URINE CHEMISTRY
METHOD
PANEL/TEST
NAME
NORMAL
INTERVAL
TEST(S)
SPECIMEN
TYPE/CONTAI
NER
AMYLASE
URINE24 HRS
59-401 U/HR
CALCIUM
URINE24 HRS
42-353 MG/
24 HRS
RANDOM
URINE*
VARIABLE
SAME AS
FOR
PLASMA
AMYLASE
SAME AS
FOR
PLASMA
CALCIUM, TIMED
SAME AS
FOR
PLASMA
CALCIUM,
RANDOM
CALCIUM
SAME AS
FOR
PLASMA
CHLORIDE, TIMED
CHLORIDE
URINE24 HRS
110-250 MMOL/24
HRS
SAME AS
FOR
PLASMA
CHLORIDE,
RANDOM
CHLORIDE
RANDOM
URINE*
VARIABLE
SAME AS
FOR
PLASMA
CREATININE,
TIMED
CREATININE
URINE24 HRS
0.6-2.5 GM/
24HRS
SAME AS
FOR
PLASMA
CREATININE,
RANDOM
CREATININE
RANDOM
URINE*
VARIABLE
SAME AS
FOR
PLASMA
GLUCOSE, TIMED
GLUCOSE
SAME AS
FOR
PLASMA
GLUCOSE,
RANDOM
SAME AS
FOR
PLASMA
PHOSPHORUS,
TIMED
SAME AS
FOR
PLASMA
PHOSPHORUS,
RANDOM
GLUCOSE
URINE24 HRS
< 0.5 GM/24HRS
RANDOM
URINE*
1-15 MG/DL
PHOSPHORUS
URINE24 HRS
0.4-1.3 GM/24HRS
PHOSPHORUS
RANDOM
URINE*
VARIABLE
Page 11 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
SAME AS
FOR
PLASMA
POTASSIUM,
TIMED
POTASSIUM
URINE24 HRS
POTASSIUM,
RANDOM
POTASSIUM
RANDOM
URINE*
SAME AS
FOR
PLASMA
URINE TOTAL
PROTEIN, TIME
TOTAL PROTEIN
URINE24 HRS
SAME AS
FOR
PLASMA
URINE PROTEIN,
RANDOM
TOTAL PROTEIN
RANDOM
URINE*
< 12.0 MG/DL
SAME AS
FOR
PLASMA
SODIUM, TIMED
SODIUM
URINE 24 HR
40-220 MMOL/24 HRS
SAME AS
FOR
PLASMA
SODIUM, RANDOM
SODIUM
RANDOM
URINE*
VARIABLE
UREA NITROGEN,
TIMED
UREA NITROGEN
URINE 24 HR
12-20 GM/24HRS
UREA NITROGEN,
RANDOM
UREA NITROGEN
RANDOM
URINE*
VARIABLE
URIC ACID, TIMED
URIC ACID
URINE24 HR
50-990 MG/24HRS
SAME AS
FOR
PLASMA
URIC ACID,
RANDOM
URIC ACID
N
MICROALBUMIN,
TIMED
ALBUMIN
N
RATIO ALBUMIN/
CREATININE
ALBUMIN
URINE
PREGNANCY
TEST
URINE HCG
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
SAME AS
FOR
PLASMA
D
RANDOM
URINE*
URINE 24 HR
RANDOM
URINE*
FIRST
MORNING
URINE
25-125 MMOL/24HRS
VARIABLE
<150 MG/24 HR.
VARIABLE
<30.0 MG/24HRS
<30.0 MG/G
NEGATIVE
Page 12 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
D
R
FP
URINALYSIS
PHYSICAL,
CHEMICAL AND
MICROSCOPIC
ANALYSIS OF
URINE
DRUG SCREEN,
URINE
OSMOLALITY,
URINE
PHYSICAL, CHEMICAL
AND MICROSCOPIC
ANALYSIS OF URINE
AMPHETAMINES
BARBITURATES
BENZODIAZEPINES
CANNABINOIDS
COCAINE
METHADONE
OPIATES
PHENCYCLIDINE
OSMOLALITY
RANDOM
URINE (3 ML) *
RANDOM
URINE *
RANDOM
URINE *
YELLOW CLEAR
GLUCOSE NEGATIVE
PH-4.6-8.0
KETONES NEGATIVE
PROTEIN
BILRUBIN NEGATIVE
BLOOD NEGATIVE
UROBILINOGEN0.1 1-10
EHRLICH UNITS
SPECIFIC GRAVITY
1.001-1.035
NITRITE NEGATIVE
URINE
LEUKOCYTE
ESTERASE=
NEGATIVE
MICRO SCOPIC:
RBC-P.3/HPF
WBC-O.5/HPF
HYALINE CASTS0-1/HPF
CUTOFF
CONCENTRATION
(ng/mL):
AMPHETAMINES 500
BARBITURATES 200
BENZODIAZEPINES 200
CANNABINOIDS 50
COCAINE 300
METHADONE 300
OPIATES 300
PHENCYCLIDINE 25
100-650
MOSMOL/KG
*STERILE CONTAINER OR YELLOW TOP TUBE (NO ADDITIVE)
Page 13 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
HEMATOLOGY
METHOD
PANEL/TEST
NAME
TEST(S)
TUBE
NORMAL INTERVAL
FLUORESCE
NT FLOW
CYTOMETRY
AUTOMATED
BLOOD COUNT
(CBC WITHOUT
DIFFERENTIAL)
WBC, RBC, HGB,
HCT, MCH, MCHC,
RDW,CPLT, MCV
LAVENDER
TOP
See Appendix
FLUORESCE
NT FLOW
CYTOMETRY
CBC WITH AUTO
DIFFERENTIAL
DIFFERENTIAL
WBC COUNT
(STKS 5 PART)
LAVENDER
TOP
See Appendix
G-6 PD
LAVENDER
TOP
See report
CER
GLUCOSE-6
PHOSPHATE
DEHYDROGENASE
KLEINHAUER
BETKE
STAIN
FLUORESCE
NT FLOW
CYTOMETRY
RESISTANCE OF
FETAL
HEMOGLOBIN TO
ACID ELUTION
LAVENDER
TOP
RETICULOCYTE
AUTOMATED
RETICULOCYTE
COUNT
LAVENDER
TOP
SEDIMENTATION
RATE
SEDIMENTATION
RATE
LAVENDER
TOP
SICKLE CELL
PREPARATION
TESTING FOR THE
PRESENCE FOR
THE PRESENCE
OF SICKLING
HEMOGLOBINS
MANUAL
SOLUBILITY
TESTING
FLOW TIME
VISCOSITY,
SERUM
FLOW TIME
VISCOSITY,
WHOLE BLOOD
VISCOSITY,
SERUM
VISCOSITY,
WHOLE BLOOD
LAVENDER
TOP
LESS THAN 1% OR
NOT FETAL CELLS
PRESENT
NEW BORN
1.0-7.0%
AFTER 6 MO.
0.4-2.5%
AGE, 0-50
0-15 MM/HR
MALE, AGE >50
0-20.0 MM/HR
FEMALE, AGE>50
0-26.0 MM/HR
NEGATIVE
RED TOP
NO GEL
RATIO: 1.4-1.8
LAVENDER
TOP
RATIO: 4.8-5.2
Page 14 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
COAGULATION
PANEL/TEST
NAME
TEST(S)
TUBE
NORMAL INTERVAL
PHOTO-OPTICAL
DETECTION
D-DIMER
D-DIMER
BLUE TOP
< 230 D-DU NG/ML
PHOTO-OPTICAL
DETECTION
FACTOR II
ASSAY
FACTOR II
ASSAY
BLUE TOP
74-142%
METHOD
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
CLAUSS
METHOD
ELECTROMECHANICAL
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
FACTOR V
ASSAY
FACTOR V
ASSAY
BLUE TOP
70-143%
FACTOR VII
ASSAY
FACTOR VII
ASSAY
BLUE TOP
53-149%
FACTOR VIII
ASSAY
FACTOR VIII
ASSAY
BLUE TOP
51-138%
FACTOR IX
ASSAY
FACTOR IX
ASSAY
BLUE TOP
69-167%
FACTOR X
ASSAY
FACTOR X
ASSAY
BLUE TOP
68-149%
FACTOR XI
ASSAY
FACTOR XI
ASSAY
BLUE TOP
73-148%
FACTOR XII
ASSAY
FACTOR XII
ASSAY
BLUE TOP
51-180%
FIBRINOGEN
FIBRINOGEN
BLUE TOP
158 - 438 MG/DL
LUPUS
ANTICOAGULA
NT PANEL
Hexagonal
DRVVT
BLUE TOP
SEE REPORT
PLATELET
AGGREGATION
PLATELET
AGGREGATION
8 BLUE TOPS AND 1
LAVENDER TOP
HAND DELIVERED
IMMEDIATELY
AFTER
COLLECTION
SEE REPORT
Page 15 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
HIGH-SHEAR
FORCE DYNAMIC
FLOW SYSTEM
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PHOTO-OPTICAL
DETECTION
PIFA
TURBIDIMETRICBASED OPTICAL
DETECTION
TURBIDIMETRICBASED OPTICAL
DETECTION
2 BLUE TOPS AND 1
LAVENDER TOP
HAND DELIVERED
IMMEDIATELY
AFTER
COLLECTION
SEE REPORT
PROTHROMBIN
TIME
BLUE TOP
PT 10.0-13.1 SEC
INR 0.87-1.16
PT MIXING
STUDY
BLUE TOP
PLATELET
FUNCTION
ASSESMENT
PLATELET
FUNCTION
ASSESMENT
PROTHROMBIN
TIME AND INR
PT MIXING
STUDY
(APTT)
ACTIVATED
PARTIAL
THROMBOPLASTIN TIME
PARTIAL
THROMBOPLASTIN TIME,
ACTIVATED
PTT MIXING
STUDY
PTT MIXING
STUDY
THROMBIN
TIME
THROMBIN
TIME
HEPARIN
INDUCED
THROMBOCYT
OPENIA
ANTIBODIES TO
PF4
VERIFYNOW
P2Y12
VERIFYNOW
ASPIRIN
HEPARIN
INDUCED
THROMBOCYT
OPENIA ABS
P2Y12
PLATELET
RESPONSE
(REACTIVITY)
ASSAY
ASPIRIN
PLATELET
RESPONSE
(REACTIVITY)
SEE REPORT
BLUE TOP
BLUE TOP
BLUE TOP
RED TOP TUBE
NO GEL
TWO 2 ML GREINER
TUBES (PLEASE
CONTACT LAB)
HAND DELIVERED
IMMEDIATELY
AFTER
COLLECTION
TWO 2 ML GREINER
TUBES (PLEASE
CONTACT LAB)
HAND DELIVERED
IMMEDIATELY
AFTER
COLLECTION
27.5-37.4 SEC
SEE REPORT
19.1-26.1 SEC
NEGATIVE
INTERPRETATION
PROVIDED
INTERPRETATION
PROVIDED
Page 16 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
SEROLOGY
METHOD
PANEL/TEST
NAME
BACTERIAL
MENINGITIS
PANEL IN SERUM
LA
BACTERIAL
MENINGITIS
PANEL IN URINE
TEST(S)
HEMOPHILUS
INFLUENZA TYPE
B, PNEUMOCCUS
AND NEISSERIA
A, B, C, AND Y
MENINGITIDES
SERO GROUPS
TUBE
CEREBROSPINAL
FLUID
NORMAL
INTERVAL
NEGATIVE
NEGATIVE
AS ABOVE
LA
URINE
LA
BACTERIAL
MENINGITIS
PANEL, SERUM
EIA
C. DIFFICILE GDH
AND TOXINS A&B,
STOOL
CLOSTRIDIUM
DIFFICILE GDH
AND TOXINS A&B
STERILE
CONTAINER
NEGATIVE
CRYPTOCOCCAL
ANTIGEN, SERUM
CRYPTOCOCCAL
ANTIGEN
SCREEN AND TITER
GOLD TOP
NEGATIVE
CRYPTOCOCCAL
ANTIGEN
SCREEN AND TITER
CSF
NEGATIVE
LA
LA
CRYPTOCOCCAL
ANTIGEN, CSF
AS ABOVE
GOLD TOP
NEGATIVE
Page 17 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
BIOFIRE
FILMARRAY RVP
RESPIRATORY
PANEL, VIRAL
AND BACTERIAL
TARGETS
STREPTO-COCCUS
GROUP B
ANTIGEN, CSF
STREPTOCOCCUS
GROUP B ANTIGEN
STREPTO-COCCUS
GROUP B
ANTIGEN, SERUM
STREPTOCOCCUS
GROUP B ANTIGEN
LA
STREPTO-COCCUS
GROUP B
ANTIGEN
URINE
STREPTOCOCCUS
GROUP B ANTIGEN
CMIA
HIV –1 &2
ANTIGEN/ANTIBODY
HIV AG/AB
SCREEN
CMIA
HEPATITIS A AB
IG G
HEPATITIS A AB
IG G
CMIA
HEPATITIS A AB
IG M
CMIA
HEPATITIS B CORE
AB TOTAL
HEPATITIS B
CORE AB TOTAL
CMIA
HEPATITIS B CORE
AB IGM
HEPATITIS B
CORE AB IGM
CMIA
HEPATITIS B
SURFACE
ANTIGEN
PCR
LA
LA
NASOPHARYNGEAL
SWAB
NEGATIVE
CSF
NEGATIVE
GOLD TOP
NEGATIVE
2ML - URINE
NEGATIVE
RED or GOLD TOP
NEGATIVE
RED or GOLD TOP
NON-REACTIVE
RED or GOLD TOP
HEPATITIS A AB
IG M
NON-REACTIVE
RED or GOLD TOP
NON-REACTIVE
RED or GOLD TOP
NON-REACTIVE
RED or GOLD TOP
HEPATITIS B
SURFACE
ANTIGEN
NON-REACTIVE
RED or GOLD TOP
CMIA
HEPATITIS B
SURFACE
ANTIBODY
HEPATITIS B
SURFACE
ANTIBODY
EXPECTED
VALUES:
NON-IMMMUNE:
NON REACTIVE
IMMUNE:
REACTIVE
Page 18 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
CMIA
HEPATITIS C AB
HEPATITIS C AB
DSI
INFECTIOUS
MONO-NUCLEOSIS
HETEROPHILE
ANTIBODIES
MONOTEST
LEGIONELLA
LEGIONELLA
URINARY
ANTIGEN
MRSA/MSSA PCR
MRSA SCREEN
RICA
PCR
STREPTOCOCCUS
GROUP A ANTIGEN
STREP A
RICA
RED or GOLD TOP
GOLD TOP
URINE
STERILE
CONTAINER OR
GRAY TOP TUBE
NASAL SWAB,
COPAN
TRANSPORT TUBE
STERILE BBL
CULTURESWAB
PLUS AMIES GEL.
DUAL SWAB FROM
THE
TONSILSAND/OR
THE BACK OF THE
THROAT
NON-REACTIVE
NEGATIVE
NEGATIVE
NEGATIVE
NEGATIVE
MISCELLANEOUS
TEST NAME
LEUKOCYTES
IN STOOL,
WRIGHT STAIN
OCCULT BLOOD
IN STOOL
CLOTEST
RAPID UREASE
TEST FOR
DIAGNOSIS OF
H. PYLORI
CONTAINER
STERILE
CONTAINER
HEMOCCULT
SLIDE OR STERILE
CONTAINER
GASTRIC BIOPSY
IN STERILE
SALINE,
STERILE TUBE
NORMAL
INTERVAL
NO WHITE
BLOOD CELLS
PRESENT
NEGATIVE
NEGATIVE
Page 19 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
MALARIA
SMEAR (AND
OTHER BLOOD
PARASITES)
LAVENDER TOP
CSF FLUID IN
STERILE TUBE
CEREBROSPINAL FLUID
CELL COUNT
BODY FLUIDS
CELL COUNT
NEGATIVE
SEE RESULT
REPORT
PERITONEAL,
PLEURAL,
SYNOVIAL FLUID,
ETC.
COLLECTED IN
LAVENDER TOP
TUBE
Tubes containing anticoagulants must be filled completely and mixed immediately after
collection by gently inverting the tube several times. Gold or red top vacuum (serum) tubes
contain clot activators and should also be mixed to accelerate clotting. Serum tubes with clot
activators may be centrifuged about 20 minutes after collection.
For coagulation tests draw a few milliliters of blood into a vacuum collection tube and discard.
Then collect a completely filled blue top citrate tube. Mix by gently inverting several times,
immediately after collection.
To ensure accurate results all the specimens have to be delivered to the laboratory within
maximum 2 hours from collection, unless stricter rules apply. The transport temperature for
specimens in transit to the laboratory has to be room temperature, unless otherwise specified
above. When specimens cannot be delivered to the laboratory within 2 hours from collection
please contact the laboratory at 212 434 2300 for temperature storage recommendations.
Blood collection tubes in use include:
MINT
4.5 ml tube with lithium heparin and a gel barrier (plasma)
GOLD
5 ml tube with gel barrier and clot activator (serum)
RED
6 ml with clot activator (serum)
BLUE
5 ml tube (4.5 ml draw) with citrate anticoagulant
GRAY
6 ml tube with fluoride and oxalate
Page 20 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
LAVENDER
3ml tube with EDTA anticoagulant
DARK GREEN
4 ml tube with heparin anticoagulant
GREINER
2 ml partial fill blue top tube containing 3.2% Sodium Citrate.
The tubes must be filled to its intended whole blood capacity (indicated
by small black line).
Minimum volume for each test, unless otherwise specified above:
 1 ml of whole blood, serum or plasma for chemistry tests
 2 ml urine for urinalysis (macroscopic only)
 3 ml urine for urinalysis (macroscopic and microscopic)
 2 ml body fluids for chemistry and cell count
 3 ml whole blood on EDTA for CBC (The tube must be more than half full for proper
anticoagulant ratio. For pediatrics, draw blood in a MICROTAINER. Do not draw a small
volume into a standard VACUTAINER).
APPENDIX
TEST
AGE
MALE
NORMAL
FEMALE
NORMAL
UNITS
CBCD - Complete blood cell count w/automated differential
WBC
0D
3D
7D
14D
1M
1
2
4
6
10
12
9.0-30.0
5.0-21.0
5.0-20.0
5.0-19.5
6.0-17.5
6.0-17.0
5.0-15.5
5.0-14.5
4.5-13.5
4.5-13.0
3.8-10.5
9.0-30.0
5.0-21.0
5.0-20.0
5.0-19.5
6.0-17.5
6.0-17.0
5.0-15.5
5.0-14.5
4.5-13.5
4.5-13.0
3.8-10.5
K/uL
RBC
0D
1D
3D
7D
14D
1M
3.95-6.55
3.84-6.44
3.81-6.41
3.56-6.16
2.90-5.50
2.70-5.30
3.95-6.55
3.84-6.44
3.81-6.41
3.56-6.16
2.90-5.50
2.70-5.30
M/uL
Page 21 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
HGB
HCT
MCV
2M
3M
6M
2
10
12
2.60-4.20
2.90-4.50
3.80-5.40
4.05-5.35
4.10-5.50
4.20-5.80
2.60-4.20
2.90-4.50
3.80-5.40
4.05-5.35
4.10-5.50
3.80-5.20
0D
1D
7D
21D
1M
2M
3M
6M
2
8
10
12.8-20.4
14.2-21.5
12.8-20.5
11.1-20.1
12.5-16.0
9.0-12.5
9.6-13.1
10.4-13.9
10.1-15.1
10.4-15.4
12.8-20.4
14.2-21.5
12.8-20.5
11.1-20.1
12.5-16.0
9.0-12.5
9.6-13.1
10.4-13.9
10.1-15.1
10.4-15.4
13.0-17.0
11.5-15.5
0D
1D
3D
7D
14D
21D
1M
2M
3M
6M
2
6
12
50.0-62.0
48.0-65.5
49.0-65.0
43.0-62.0
41.0-62.0
40.0-52.0
37.0-49.0
26.0-36.0
28.0-38.0
31.0-41.0
33.0-43.5
34.5-45.0
50.0-62.0
48.0-65.5
49.0-65.0
43.0-62.0
41.0-62.0
40.0-52.0
37.0-49.0
26.0-36.0
28.0-38.0
31.0-41.0
33.0-43.5
34.5-45.0
39.0-50.0
34.5-45.0
0D
1D
3D
7D
14D
21D
1M
2M
3M
6M
110.6-129.4
109.6-128.4
106.6-125.4
96.0-134.0
93.0-131.0
92.0-130.0
86.0-124.0
83.0-103.0
78.0-98.0
71.0-84.0
73.0-87.0
110.6-129.4
109.6-128.4
106.6-125.4
96.0-134.0
93.0-131.0
92.0-130.0
86.0-124.0
83.0-103.0
78.0-98.0
71.0-84.0
73.0-87.0
2
g/dL
%
fL
Page 22 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
MCH
6
8
12
74.0-89.0
74.5-91.5
80.0-100.0
74.0-89.0
74.5-91.5
80.0-100.0
0D
1D
3D
7D
14D
21D
1M
2M
3M
6M
31.0-37.0
33.9-39.9
33.5-39.5
33.2-39.2
33.8-39.8
34.1-40.1
32.5-38.5
28.5-34.5
27.5-33.5
24.0-30.0
22.0-28.0
24.0-30.0
27.0-34.0
31.0-37.0
33.9-39.9
33.5-39.5
33.2-39.2
33.8-39.8
34.1-40.1
32.5-38.5
28.5-34.5
27.5-33.5
24.0-30.0
22.0-28.0
24.0-30.0
27.0-34.0
pg
29.7-33.7
29.6-33.6
29.1-33.1
30.0-34.0
30.1-34.1
31.9-35.9
31.5-35.5
32.1-36.1
32.8-36.8
32.0-36.0
31.0-35.0
32.0-36.0
31.0-35.0
32.0-36.0
29.7-33.7
29.6-33.6
29.1-33.1
30.0-34.0
30.1-34.1
31.9-35.9
31.5-35.5
32.1-36.1
32.8-36.8
32.0-36.0
31.0-35.0
32.0-36.0
31.0-35.0
32.0-36.0
g/dL
12.5-17.5
11.7-16.3
11.6-15.1
11.1-14.6
10.3-16.9
%
2
10
12
12.5-17.5
11.7-16.3
11.6-15.1
11.1-14.6
10.3-16.9
0D
1D
150-350
120-340
150-350
120-340
K/uL
1
4
12
MCHC
0D
1D
3D
7D
14D
21D
1M
2M
3M
6M
1
4
6
12
RDW
0D
2M
PLT
Page 23 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
7D
1M
120-370
150-400
120-370
150-400
AUTOMATED DIFFERENTIAL
% NEUTROPHILS
0D
3D
7D
14D
1M
1
2
4
6
10
12
43.0-77.0
30.0-60.0
33.0-57.0
18.0-52.0
15.0-49.0
16.0-50.0
26.0-60.0
35.0-69.0
38.0-72.0
40.0-74.0
43.0-77.0
43.0-77.0
30.0-60.0
33.0-57.0
18.0-52.0
15.0-49.0
16.0-50.0
26.0-60.0
35.0-69.0
38.0-72.0
40.0-74.0
43.0-77.0
%
% LYMPHOCYTES
0D
16.0-47.0
26.0-56.0
33.0-63.0
41.0-71.0
46.0-76.0
44.0-74.0
35.0-65.0
27.0-57.0
18.0-49.0
14.0-45.0
13.0-44.0
16.0-47.0
26.0-56.0
33.0-63.0
41.0-71.0
46.0-76.0
44.0-74.0
35.0-65.0
27.0-57.0
18.0-49.0
14.0-45.0
13.0-44.0
%
2.0-8.0
2.0-11.0
2.0-9.0
2.0-7.0
2.0-14.0
2.0-8.0
2.0-11.0
2.0-9.0
2.0-7.0
2.0-14.0
%
0.0-4.0
0.0-5.0
0.0-6.0
0.0-4.0
0.0-5.0
0.0-6.0
%
7D
10
0D
0.0-2.0
0.0-2.0
%
3D
7D
14D
1M
1
2
4
6
10
12
% MONOCYTES
0D
3D
14D
1M
12
% EOSINOPHILS
% BASOPHILS
0D
Related documents
For Microbiology Specimens see policy 90.1.6.11.4 (TX. PC 885)
Page 24 of 23
90.1.6.11.2 Specimen Collection: Clinical Laboratories,
Blood Collection, Tube Requirements and Normal Intervals
Effective Date: 12-01-15
100 East 77th Street
New York, N.Y. 10075
Revision/Version No.
Date
Additions/Amendments
1
6/7/2010
New. Replacing 886TXPC with original issue date of 3/1998
2
02/16/2015
3
10/26/2015
4
12/01/2015
Removed: ACET, SLAP, RET
Added: BHB
Changed: ALPi
Number reassigned from 886TXPC to 90.1.6.11.2
Changed reference ranges for: ALP, ALT, Ammonia, TBIL, IOPTH,
Lactic acid, Phosphorus, Mg, BNP, Haptoglobin, Sodium (plasma), TT4,
FT4, FT3, TSH, cortisol, Coagulation tests.
Removed: Flu Antigen, RPR, UCRP, Homocysteine, RF, C3, C4, AFP,
CEA, Fluid CEA, cortisol (random), Factor XIII deficiency screen,
Hepatitis A Ig Total.
Added: Osmolality serum and urine, Biofire RVP, VerifyNow testing,
PIFA HIT, Indirect Bilirubin, Anion Gap, Appendix, eGFR, Strep A,
MRSA/MSSA by PCR, GDH to the C. difficille testing, Ag to HIV
screen, Hepatitis A Ig G.
Updated reference range for PT from 9.4-13.0 to 10.0-13.1 sec. Added
minimum volume requirements and discription of collection tubes.
Page 25 of 23